Loading company details...
Beta
Latest Form 4 (Oct 7, 2026): Stuart Naylor (CHIEF SCI OFCR, OPHTHALMOLOGY): Sale of 27,659 shares, $294.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Stuart Naylor, CHIEF SCI OFCR, OPHTHALMOLOGY | Sale | 27,659 | $294.3K |
| Sep 25, 2026 | Alan Sebulsky | Grant/Award | 100,000 | n/a |
| Aug 19, 2026 | Alexandria Forbes, PRESIDENT & CEO | Sale | 62,000 | $859.3K |
| Jul 22, 2026 | Richard Giroux, CFO & COO | Sale | 56,000 | $700.6K |
| Jul 8, 2026 | Stuart Naylor, CHIEF SCI OFCR, OPHTHALMOLOGY | Sale | 2,547 | $35.3K |
| Jun 30, 2026 | Robert K. Zeldin, CHIEF MEDICAL OFFICER | Grant/Award | 100,000 | n/a |
| Jun 30, 2026 | Robert J. Wollin, GENERAL COUNSEL AND SECRETARY | Grant/Award | 100,000 | n/a |
| Jun 30, 2026 | Stuart Naylor, CHIEF SCI OFCR, OPHTHALMOLOGY | Grant/Award | 70,000 | n/a |
| Jun 30, 2026 | Richard Giroux, CFO & COO | Grant/Award | 980,000 | n/a |
| Jun 30, 2026 | Alexandria Forbes, PRESIDENT & CEO | Grant/Award | 980,000 | n/a |